140 related articles for article (PubMed ID: 36607799)
1. Iron chelation therapy to prevent poststroke cognitive impairments: role of diabetes and sex.
Sakamuri SSVP; Sure VN; Katakam PVG
Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H210-H211. PubMed ID: 36607799
[No Abstract] [Full Text] [Related]
2. Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis.
Li W; Abdul Y; Chandran R; Jamil S; Ward RA; Abdelsaid M; Dong G; Fagan SC; Ergul A
Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H212-H225. PubMed ID: 36563009
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis.
Abdul Y; Li W; Ward R; Abdelsaid M; Hafez S; Dong G; Jamil S; Wolf V; Johnson MH; Fagan SC; Ergul A
Transl Stroke Res; 2021 Aug; 12(4):615-630. PubMed ID: 32875455
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine pre-treatment protects against postoperative cognitive dysfunction of aged rats by depressing microglial activation via ameliorating iron accumulation in hippocampus.
Pan K; Li X; Chen Y; Zhu D; Li Y; Tao G; Zuo Z
Neuropharmacology; 2016 Dec; 111():180-194. PubMed ID: 27608977
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin ameliorates cognitive dysfunction in mice with type 2 diabetes mellitus via inhibiting iron overload and ferroptosis.
Guo T; Yu Y; Yan W; Zhang M; Yi X; Liu N; Cui X; Wei X; Sun Y; Wang Z; Shang J; Cui W; Chen L
Exp Neurol; 2023 Jul; 365():114414. PubMed ID: 37075971
[TBL] [Abstract][Full Text] [Related]
6.
Tang W; Li Y; He S; Jiang T; Wang N; Du M; Cheng B; Gao W; Li Y; Wang Q
Antioxid Redox Signal; 2022 Nov; 37(13-15):867-886. PubMed ID: 35350885
[No Abstract] [Full Text] [Related]
7. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction.
Zeinivand M; Nahavandi A; Zare M
Inflammopharmacology; 2020 Apr; 28(2):575-583. PubMed ID: 31786804
[TBL] [Abstract][Full Text] [Related]
8. Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis.
Xie Z; Wang X; Luo X; Yan J; Zhang J; Sun R; Luo A; Li S
Biochem Pharmacol; 2023 Jan; 207():115374. PubMed ID: 36502872
[TBL] [Abstract][Full Text] [Related]
9. [Hippocampal neuronal ferroptosis involved in cognitive dysfunction in rats with sepsis-related encephalopathy through the Nrf2/GPX4 signaling pathway].
Yao P; Chen Y; Li Y; Zhang Y; Qi H; Xu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1389-1394. PubMed ID: 31898571
[TBL] [Abstract][Full Text] [Related]
10. SLC40A1 Mediates Ferroptosis and Cognitive Dysfunction in Type 1 Diabetes.
Hao L; Mi J; Song L; Guo Y; Li Y; Yin Y; Zhang C
Neuroscience; 2021 May; 463():216-226. PubMed ID: 33727075
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of nimodipine and deferoxamine on brain injury in rat with subarachnoid hemorrhage.
Qin Y; Li G; Sun Z; Xu X; Gu J; Gao F
Behav Brain Res; 2019 Jul; 367():194-200. PubMed ID: 30953658
[TBL] [Abstract][Full Text] [Related]
12. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.
Cameron NE; Cotter MA
J Clin Invest; 1995 Aug; 96(2):1159-63. PubMed ID: 7635953
[TBL] [Abstract][Full Text] [Related]
13. Nox4-and Tf/TfR-mediated peroxidation and iron overload exacerbate neuronal ferroptosis after intracerebral hemorrhage: Involvement of EAAT3 dysfunction.
Xie J; Lv H; Liu X; Xia Z; Li J; Hong E; Ding B; Zhang W; Chen Y
Free Radic Biol Med; 2023 Apr; 199():67-80. PubMed ID: 36805044
[TBL] [Abstract][Full Text] [Related]
14. Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization.
Jackson L; Dong G; Althomali W; Sayed MA; Eldahshan W; Baban B; Johnson MH; Filosa J; Fagan SC; Ergul A
Transl Stroke Res; 2020 Aug; 11(4):762-775. PubMed ID: 31792796
[TBL] [Abstract][Full Text] [Related]
15. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522
[TBL] [Abstract][Full Text] [Related]
16. Deferoxamine ameliorated Al(mal)
Zhu D; Liang R; Liu Y; Li Z; Cheng L; Ren J; Guo Y; Wang M; Chai H; Niu Q; Yang S; Bai J; Yu H; Zhang H; Qin X
Toxicol Mech Methods; 2022 Sep; 32(7):530-541. PubMed ID: 35313783
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy.
Sheth S; Ruzal-Shapiro C; Hurlet-Jensen A; Piomelli S; Berdon WE
Pediatr Radiol; 1997 Dec; 27(12):926-8. PubMed ID: 9388284
[TBL] [Abstract][Full Text] [Related]
18. Klotho ameliorated cognitive deficits in a temporal lobe epilepsy rat model by inhibiting ferroptosis.
Xiang T; Luo X; Zeng C; Li S; Ma M; Wu Y
Brain Res; 2021 Dec; 1772():147668. PubMed ID: 34592245
[TBL] [Abstract][Full Text] [Related]
19. Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex.
Ward R; Valenzuela JP; Li W; Dong G; Fagan SC; Ergul A
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1402-H1413. PubMed ID: 30118341
[TBL] [Abstract][Full Text] [Related]
20. Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity.
DeBoer DA; Clark RE
Ann Thorac Surg; 1992 Mar; 53(3):412-8. PubMed ID: 1540057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
